Glycans as Potential Diagnostic Markers of Traumatic Brain Injury

dc.contributor.authorKvist Mårten
dc.contributor.authorVälimaa Lasse
dc.contributor.authorHarel Adrian
dc.contributor.authorPosti Jussi P
dc.contributor.authorRahi Melissa
dc.contributor.authorSaarenpää Ilkka
dc.contributor.authorVisuri Mikko
dc.contributor.authorÖstberg Anna
dc.contributor.authorRinne Jaakko
dc.contributor.organizationfi=kirurgia|en=Surgery|
dc.contributor.organizationfi=kliininen laitos|en=Department of Clinical Medicine|
dc.contributor.organizationfi=kliiniset neurotieteet|en=Clinical Neurosciences|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.61334543354
dc.contributor.organization-code1.2.246.10.2458963.20.74845969893
dc.contributor.organization-code2607300
dc.contributor.organization-code2607309
dc.converis.publication-id67989137
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/67989137
dc.date.accessioned2022-10-28T14:16:49Z
dc.date.available2022-10-28T14:16:49Z
dc.description.abstract<p>The diagnosis of mild traumatic brain injury (TBI) is challenging in the acute setting because the symptoms are nonspecific and often transient, or they develop with a delay. In these cases, the criteria for acute head imaging are frequently not fulfilled. This may lead to missed diagnoses in emergency care. There is a need for developing a rapid diagnostic test to verify the presence of TBI using body fluids. Blood, urine, and saliva samples from 11 adult patients (mean age 64 years, SD 24 years) with acute and clinically diagnosed TBI, and 12 healthy volunteers were collected at Turku University Hospital during a period of 5 months. The injuries necessitated hospitalization for at least one day. The TBIs were classified mild in nine cases and severe in two cases. The mean period between the trauma and the time for obtaining the samples was 27 h, SD 11 h. The samples were analyzed in an ISO-certified laboratory for the number of lectin-bound glycan molecules indicating destruction of nerve tissue. The screening was performed on several possible glycans for binding, and the measurement by degree of fluorescence. In the analysis, the group of patients with TBI was compared with healthy volunteers. The results showed a significant decrease (p < 0.05, Wilcoxon rank–sum two-sided test) in the level of two glycans in plasma, but no significant increase for any glycan; in saliva, one glycan showed a significant increase in the TBI group; in urine, three glycans were significantly different between the groups (one showed an increase, whereas two showed a decrease). The results support the idea of conducting more research on how diagnostic glycans could be detected in body fluids after TBI. As a proof-of-concept, significant changes in the concentration of five glycans were found in plasma, saliva, and urine between TBI patients and healthy controls. This may enable the development of a rapid body fluid-based point-of-care test to identify patients with TBI after a head injury.</p>
dc.identifier.jour-issn2076-3425
dc.identifier.olddbid187345
dc.identifier.oldhandle10024/170439
dc.identifier.urihttps://www.utupub.fi/handle/11111/39556
dc.identifier.urnURN:NBN:fi-fe2022012711003
dc.language.isoen
dc.okm.affiliatedauthorPosti, Jussi
dc.okm.affiliatedauthorSaarenpää, Ilkka
dc.okm.affiliatedauthorVisuri, Mikko
dc.okm.affiliatedauthorÖstberg, Anna
dc.okm.affiliatedauthorRinne, Jaakko
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3124 Neurology and psychiatryen_GB
dc.okm.discipline3124 Neurologia ja psykiatriafi_FI
dc.okm.internationalcopublicationnot an international co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisher.countrySwitzerlanden_GB
dc.publisher.countrySveitsifi_FI
dc.publisher.country-codeCH
dc.relation.articlenumber1480
dc.relation.doi10.3390/brainsci11111480
dc.relation.ispartofjournalBrain Sciences
dc.relation.issue11
dc.relation.volume11
dc.source.identifierhttps://www.utupub.fi/handle/10024/170439
dc.titleGlycans as Potential Diagnostic Markers of Traumatic Brain Injury
dc.year.issued2021

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
brainsci-11-01480-v3.pdf
Size:
652.45 KB
Format:
Adobe Portable Document Format
Description:
Publisher's version